Sargramostim With Ipilimumab Containing Therapy in Patients With Solid Tumors

Clinical trial NCT05284214 · WITHDRAWN

Trial details

NCT number: NCT05284214
Sponsor: Partner Therapeutics, Inc.
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Solid Tumor Solid Tumor, Adult

Start date: 2024-01-01
Primary completion: 2025-09-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.